Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tatelo Study: Dual bNAb Treatment in Children with HIV
NCT03707977Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2019
- Primary completion
- Dec 2021
- Modality
- Anti-infectious Disease mAbs
- Countries
- 1
01
Overview
A Phase 2 trial of VRC01LS, zinlirvimab in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2019; status: completed.
02
Drugs
VRC01LSzinlirvimab
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03707977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707977.